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Endothelial cell (EC) migration is a critical event during multiple physiological and pathological
processes. ECs move in the plane of the endothelium to heal superficially injured blood vessels but
migrate in three dimensions during angiogenesis. We herein investigate differences in these
modes of movement focusing on caveolae and their defining protein caveolin-1. Using a novel
approach for morphological analysis of transmigrating cells, we show that ECs exhibit a polarized
distribution of caveolin-1 when traversing a filter pore. Strikingly, in these cells caveolin-1 seems
to be released from caveolar structures in the cell rear and to relocalize at the cell front in a
cytoplasmic form. In contrast, during planar movement caveolin-1 is concentrated at the rear of
ECs, colocalizing with caveolae. The phosphorylatable Tyr14 residue of caveolin-1 is required for
polarization of the protein during transmigration but does not alter polarization during planar
movement. Palmitoylation of caveolin-1 is not essential for redistribution of the protein during
either mode of movement. Thus, ECs migrating in three dimensions uniquely exhibit dissociation
of caveolin-1 from caveolae and phosphorylation-dependent relocalization to the cell front.
INTRODUCTION
Endothelial cell (EC) migration is an essential component of
vasculogenesis and angiogenesis, processes by which new
blood vessels are created or capillaries are formed from
preexisting blood vessels, respectively (Anand-Apte and
Fox, 2002). EC migration is also a critical step in the regen-
eration of the endothelium after arterial injury (Hauden-
schild and Schwartz, 1979). The topology of EC movement
during these events differs significantly, namely, blood ves-
sel formation is a three-dimensional process in which ECs
exit the plane of the endothelium, whereas wound healing is
a two-dimensional process in which ECs remain within this
plane. EC locomotion on flat surfaces in vitro is similar to
that of fibroblasts and other crawling cells and is character-
ized by a spatially polarized series of events: protrusion of a
lamellipodium and filopodia at the leading edge, attachment
to the substratum, forward flow of cytosol, and focal adhe-
sion loosening and tail retraction at the rear of the cell.
Intracellular, motility-related structures and processes also
exhibit anterior-posterior polarization in crawling cells, in-
cluding integrin-cytoskeleton interactions (Schmidt et al.,
1993); actin polymerization/depolymerization; and translo-
cation of multiple motor, regulatory, and signaling mole-
cules (Kolega, 1998; Lawrence and Singer, 1986). Much less
is known about the polarization of cellular structures during
three-dimensional migration through pores, possibly be-
cause of methodological difficulties imposed by the experi-
mental system.
Caveolae are cave-like invaginations at the surface of mul-
tiple cell types and are particularly abundant in vascular
ECs (Simionescu et al., 1982; Lisanti et al., 1994). They are
specialized membrane subdomains rich in glycosphingolip-
ids and cholesterol and also in lipid-anchored membrane
proteins. The major protein component of caveolae is caveo-
lin-1, an integral membrane protein with an unusual hair-
pin-like conformation in which the N- and C-terminal re-
gions both face the cytosol and are connected by a
membrane-embedded, hydrophobic domain (Dupree et al.,
1993). Caveolin-1 is found as two major isoforms, caveo-
lin-1 and -1, derived from alternate translation-initiation
sites of the same transcript; the smaller -isoform lacks 31
amino acids at the N terminus (Scherer et al., 1995). Caveo-
lin-1 participates in multiple protein–protein and protein–
lipid interactions that are critical for its diverse functions.
Caveolin-1 is subject to two types of posttranslational mod-
ifications that regulate its intracellular localization or activ-
ity, namely, phosphorylation and palmitoylation. Several
stimuli, including oxidative stress, induce phosphorylation
of caveolin-1 on Tyr14 (Volonte et al., 2001; Parat et al., 2002;
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Sanguinetti and Mastick, 2003). Like many caveolae-targeted
proteins, caveolin-1 is acylated; three Cys residues near the
C termini (of both - and -isoforms) are susceptible to
palmitoylation (Dietzen et al., 1995). Palmitoylation is not
required for caveolin-1 targeting to caveolae (Dietzen et al.,
1995; Uittenbogaard and Smart, 2000), but mutation of the
Cys residues impairs caveolin-1 interaction with other acy-
lated proteins (Lee et al., 2001) and its binding and transport
of cholesterol (Uittenbogaard and Smart, 2000).
Caveolin-1 may have an important role in cell motility
because it exhibits anterior-posterior polarization during cell
migration. Caveolin-1 was reported to accumulate at the
leading edge of cultured fibroblasts (Rothberg et al., 1992),
human umbilical vein smooth muscle cells (Okada et al.,
1995), and caveolin-deficient FRT cells expressing recombi-
nant caveolin-1 (Scherer et al., 1995). In contrast, caveolin-1
accumulated in the trailing edge of bovine aortic ECs (Isshiki
et al., 2002). Caveolae or lipid rafts also exhibit pronounced
polarity during cell migration. Raft-associated ganglioside
GM1 was found at the leading edge of human adenocarci-
noma MCF-7 cells stimulated with insulin growth factor-1
(Man˜es et al., 1999). Cholesterol depletion disrupted raft
formation and cellular acquisition of polarity, indicating a
functional role of the rafts and that raft movement to the
front of the cell may be critical for polarization of motility-
related, raft-associated proteins. The same laboratory subse-
quently reported that ganglioside GM1 was in the rear of a
moving T lymphocyte (Go´mez-Mouto´n et al., 2001). Herein,
we investigate the polarization of caveolin-1 and caveolae in
a single cell type, namely, aortic EC, during two modes of
movement: two-dimensional movement in response to the
wounding of a monolayer and three-dimensional movement
during transmigration through a pore. We have observed
differential polarization of caveolin-1 in the two migration
modes and that Tyr14 is critical for caveolin-1 polarization
only during transmigration.
MATERIALS AND METHODS
Rabbit anti-caveolin-1 and mouse anti-phosphocaveolin-1 antibod-
ies were obtained from Transduction Laboratories (Lexington, KY).
Alexa Fluor 488-phalloidin was from Molecular Probes (Eugene,
OR). Biotinylated goat anti-rabbit antibody, Texas Red-avidin, and
Vectashield mounting medium were from Vector Laboratories (Bur-
lingame, CA). Gold-conjugated goat anti-rabbit IgG was purchased
from Ted Pella (Redding, CA). Monoclonal anti-green fluorescent
protein (GFP) antibody was from BD Biosciences Clontech (Palo
Alto, CA). Basic fibroblast growth factor (FGF) was from Upstate
Biotechnology (Lake Placid, NY). Rat tail collagen and all other
reagents were from Sigma-Aldrich (St. Louis, MO).
Cell Culture
Bovine aortic ECs were isolated as described previously (Fox and
DiCorleto, 1984) and maintained in DMEM and F12 medium sup-
plemented with 5% fetal bovine serum, 100 U ml1 penicillin, and
100 g ml1 streptomycin, in a humidified atmosphere containing
5% CO2. In some experiments, ECs were grown on chamber slides
(Falcon; BD Biosciences, Franklin Lakes, NJ).
Determination of Caveolin-1 Localization in
Transmigrating ECs
A Boyden migration chamber was prepared with serum-free media
alone or with 10 ng ml1 of basic FGF in the lower well. Polycar-
bonate membranes with 8-m pores (Neuro Probe, Gaithersburg,
MD) precoated overnight with rat tail collagen type 1 (100 g ml1
in 0.2 N acetic acid) and air-dried, were used to separate the cham-
bers. After pH equilibration of the chamber in a 5% CO2-containing
atmosphere, a suspension of 300,000 cells/ml in serum-free medium
was added to the upper well, and cells were allowed to attach and
migrate for 2 h. For immunofluorescence, the polycarbonate mem-
brane was then washed in phosphate-buffered saline (PBS), fixed,
permeabilized, and immunostained as described. The membranes
were mounted between slide and coverslip by using mounting
medium (Vectashield; Vector Laboratories) before visualization by
confocal immunofluorescence microscopy. In some experiments, the
membranes were cut into 0.2-cm2 pieces and processed for electron
microscopy.
Detection of Caveolin-1 in ECs by
Immunofluorescence Microscopy
ECs were washed with PBS, fixed with 3.7% formaldehyde in PBS
for 20 min, and then washed three times (this treatment and all
subsequent treatments were done at room temperature). The cells
were permeabilized with 0.1% Triton X-100 for 10 min and washed.
To reduce nonspecific binding of antibody, cells were preincubated
with 3% goat serum (Invitrogen, Carlsbad, CA) in PBS for 20 min.
ECs were then incubated with anti-caveolin-1 polyclonal antibody
(1 g ml1) in a solution containing 1.5% goat serum in PBS for 60
min. After three washes with PBS and a 5-min incubation with 3%
nonimmune goat serum, the cells were incubated with biotinylated
goat anti-rabbit antibody (1:1000) in 1.5% goat serum for 45 min.
After washing, cells were incubated with Texas Red-avidin (1:1000
in PBS) for 10 min, washed, and placed in Vectashield mounting
medium. No reactivity was observed when the primary antibody
was substituted with nonimmune rabbit IgG (1 g ml1), or with
buffer. Autofluorescence of ECs was not detectable under our ex-
perimental conditions.
Determination of Caveolin-1 Localization in
Migrating ECs by Immunoelectron Microscopy
After 24 h of migration in the planar wounding assay or 2 h of
migration through the pores of collagen-coated polycarbonate
membranes, ECs were fixed with 4% paraformaldehyde and 0.05%
glutaraldehyde in PBS at room temperature, rinsed, permeabilized
with 0.7% saponin in PBS for 10 min, and washed with PBS. Cells
were dehydrated on ice by using solutions from 30 to 95% ethanol
containing 1 mg ml1 sodium borohydrate, and rehydrated using
solutions from 70 to 30% ethanol for 2 min each on ice. Cells were
then washed and preincubated for 1 h in PBS containing 0.1%
saponin and 1% bovine serum albumin (BSA). Cells were incubated
overnight at 4°C in a humidified chamber with rabbit anti-caveo-
lin-1 IgG or control rabbit IgG (1:500 in PBS containing 0.1% saponin
and 1% BSA), washed, and placed for 30 min in a solution of 0.1%
gelatin and 0.1% BSA in PBS. Cells were incubated for 1 h in 5-nm
gold-conjugated goat anti-rabbit IgG (1:10) in PBS containing 0.1%
gelatin and 0.1% BSA, washed, and fixed in 1.33% glutaraldehyde in
0.1 M sodium cacodylate for 20 min. Cells were rinsed in 0.1 M
sodium cacodylate and incubated 5 min with 0.1 M ammonium
chloride in 0.1 M sodium cacodylate. Cells were postfixed for 2 h at
4°C in 1% osmium tetraoxide containing 1.5% potassium ferricya-
nide. Samples were dehydrated before eponate infiltration and em-
bedding. No gold particles could be observed when the anti-caveo-
lin-1 IgG was replaced by nonimmune rabbit IgG.
Expression of Caveolin-1-GFP in ECs
Full-length human caveolin-1 cDNA was obtained from American
Type Culture Collection (Manassas, VA) and subcloned into the
EcoR1 and NotI sites of pcDNA3 (Invitrogen). C-Terminal-tagged
caveolin-1-GFP was made by polymerase chain reaction (PCR) am-
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plification of caveolin-1 from pcDNA3-caveolin-1 by using a T7
primer and 5-CGGTACCGTTATTTCTTTCTGCAAGTTGATGCG,
followed by the cloning of the EcoR1-KpnI fragment from the PCR
product into a pEGFP-N1 expression vector (BD Biosciences Clon-
tech). The resulting construct (caveolin-1-GFP) encoded the human
caveolin-1 open reading frame in-frame and upstream of the en-
hanced GFP sequence with a 12-amino acid spacer, all driven by a
cytomegalovirus promoter. C-Terminal–tagged caveolin-1 behaves
in the same way as endogenous caveolin-1, including oligomeriza-
tion (Pelkmans et al., 2001), whereas N-terminally tagged caveolin-1
is a dominant-negative inhibitor of simian virus 40 internalization.
We also generated palmitoylation-deficient caveolin-1-GFP in
which Cys133, Cys143, and Cys156 were simultaneously mutated to
Ser by using 5-AGTTGTACCATCTATTAAGAGCTTCCTGATT-
GAGATTCAGTCTATCAGCCGTGTCTATTCCATCTACGTCCAC-
ACCGTCTCTGACCCACT to introduce the mutations, and a phos-
phorylation-deficient, C-terminal GFP-tagged caveolin-1 in which
Tyr14 was mutated to Ala (A14) by using 5-ATGGGAACGGTGGC-
GAGATGTC. Caveolin-1-GFP was generated from caveolin-1-GFP
by using 5-AACTGCAGCAAGGCCATG and 5-CTTGCTCAC-
CATGGTGGC as primers for PCR, and the Pst-1-BamH1 fragment
of the PCR product was cloned into pEGFP-N1. ECs were trans-
fected using lipofectin (Invitrogen) according to the manufacturer’s
instructions.
Immunoblot Analysis of Phosphocaveolin-1 and
Caveolin-1-GFP
ECs were washed twice in PBS and lysed at 4°C in buffer containing
50 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA, 2.5 mM MgCl2,
0.5% sodium deoxycholate, 1% NP-40, 20 g ml1 aprotinin, and 5
g ml1 leupeptin for 90 min. Cells were scraped, and the lysate
was cleared by centrifugation at 16,000  g for 3 min and added to
SDS (0.1% final concentration). Anti-caveolin-1 antibody was added
for 90 min, followed by protein A-Sepharose for 60 min. A control
cell lysate was immunoprecipitated with rabbit nonimmune IgG.
Immunoprecipitated complexes were washed three times, separated
by SDS-PAGE, and transferred to nitrocellulose. Phosphocaveolin-1
was detected by immunoblot analysis with monoclonal anti-phos-
phocaveolin-1 as primary antibody and peroxidase-conjugated sec-
ondary antibody. Caveolin-1-GFP was detected on the same blot
after stripping by using monoclonal anti-GFP primary antibody.
Blots were developed by chemiluminescence with ECL and Hyper-
film-ECL (Amersham Biosciences, Piscataway, NJ).
Determination of Caveolin-1 Palmitoylation in ECs
by Metabolic Labeling with [3H]Palmitate
Caveolin-1 palmitoylation was measured essentially as described
previously (Parat and Fox, 2001). Confluent ECs in 35-mm dishes
were washed with serum-free DMEM and then incubated for 2 h in
the same medium. ECs were radiolabeled for 4 h by incubation with
[3H]palmitic acid (250 Ci/ml) in serum-free medium containing
3.5 mg/ml fatty acid-free bovine serum albumin, and the cells lysed.
Caveolin-1 and caveolin-1-GFP were immunoprecipitated using
rabbit polyclonal anti-caveolin-1 antibody and subjected to SDS-
PAGE as described above. Radiolabel was determined by fluorog-
raphy after 1- and 6-mo exposure for endogenous caveolin-1 and for
transfected caveolin-1-GFP, respectively.
RESULTS
The Vector of Caveolin-1 Polarization Depends on
the Mode of EC Migration
To visualize caveolin-1 during transmigration, bovine aortic
ECs were placed in the upper well of a Boyden chamber and
permitted to migrate for 2 h through 8-m pores of a colla-
gen-coated membrane toward basic FGF placed in the lower
wells. To establish that transmigrating cells could be visu-
alized by fluorescence confocal microscopy, the membrane
was fixed and actin filaments stained with fluorescently
labeled phalloidin (Alexa Fluor 488-phalloidin). Cross sec-
tions (xz-planes) through the filter showed ECs on the filter
surface with large protrusions extending into the pore,
sometimes reaching the lower face of the filter (Figure 1A).
Caveolin-1 was visualized with polyclonal rabbit anti-caveo-
lin-1, biotinylated anti-rabbit IgG, and Texas Red-avidin.
Transmigrating ECs showed abundant and polarized accu-
mulation of caveolin-1 that was primarily restricted to the
protrusion extending into the pore (Figure 1B). A series of
cross-sectional views through the pore showed that caveo-
lin-1 was not confined to the plasma membrane, but instead
was distributed throughout the cytoplasm of the protrusion
(Figure 1, C–E). Caveolin-1 was observed in the forward
extensions of most transmigrating ECs, including those in
earlier stages of transmigration with small protrusions into
the pore (Figure 1, F and G). Occasionally, caveolin-1 was
present in small, discrete patches decorating the rear of the
cell (Figure 1B). Specificity of caveolin-1 immunostaining
was established by a control in which primary anti-caveolin
IgG was replaced by nonimmune rabbit IgG (Figure 1H).
Our findings seemed to be inconsistent with a recent
report of caveolin-1 accumulating primarily at the trailing
edge of aortic ECs induced to migrate by wounding a mono-
layer or by exposing cells to shear stress (Isshiki et al., 2002).
The apparent discrepancy may be explained by the different
modes of migration in the experiments, i.e., two-dimen-
sional movement in the wound-healing assay versus three-
dimensional movement in the transmigration assay. To test
whether the mode of movement was critical in determining
the polarization vector, caveolin-1 was observed in cells
induced to move in two dimensions by wounding an EC
monolayer. Assuming that ECs move from the dense, un-
disturbed region of cells into the cell-free wound area,
caveolin-1 seemed to concentrate in the rear of most cells
(marked by arrows in Figure 2, A and B), a finding consis-
tent with that of Isshiki et al. (2002). However, caveolin-1
seemed to concentrate in the front or sides of other cells
(Figure 2, A and B, arrowheads). Thus, polarization may
vary from cell to cell, or more likely, the perceived variabil-
ity may result from an uncertainty in the direction of cell
movement in a static view.
To rigorously assess the orientation of caveolin-1 polar-
ization in ECs moving on a flat surface, time-lapse videomi-
croscopy was used to determine the direction of EC move-
ment. To detect caveolin-1 in live cells, ECs were transiently
transfected with a pEGFP-N1 expression vector encoding
chimeric caveolin-1-GFP, and the expressed protein was
detected by the green fluorescence. Colocalization of exog-
enous caveolin-1-GFP (Figure 2C) and cellular caveolin-1
(Figure 2D) in migrating ECs was shown in an overlay of the
two images (Figure 2E). A time-lapse experiment was done
in which the monolayer of transfected ECs was wounded,
and fluorescent light images (Figure 2, F–J) and transmitted
light images (Figure 2, K–O) of the wound edge were cap-
tured. About 6 h after wounding, caveolin-1-GFP was
clearly concentrated at the rear half of an EC migrating into
the cell-free area of the dish. In this and other time-lapse
series, caveolin-1 polarization coincided with the generation
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of morphological cell polarity. Interestingly, the fragment of
cellular material that EC sometimes leave behind after tail
retraction was highly enriched in caveolin-1-GFP (Figure 2,
I and J). In control ECs transfected with the empty
pEGFP-N1 vector, GFP was uniformly distributed through-
out the cytosol, including the lamellipodium, of migrating
ECs (our unpublished data). In other time-lapse images of
isolated ECs, we excluded the possibility that caveolin-1
localization was influenced by cell-to-cell contacts that are
primarily in the rear of cells, leaving a confluent region. For
example, Figure 2, P–R, shows an isolated EC in which
caveolin-1 was localized almost exclusively in the cell rear,
whereas the cell moved rapidly away from the confluent
region. After 15 h, the cell stopped its forward movement
and reversed direction. During the short time it took to
change direction, caveolin-1 depolarized and redistributed
primarily in the central region of the cell (Figure 2S). The
caveolin-1 then repolarized in the opposite end of the elon-
gated cell as it began to move in the reverse direction (Figure
2, T and U). These results indicate that the orientation of
caveolin-1 polarization during two-dimensional, wound-in-
duced migration is opposite to that observed during three-
dimensional, transmigratory EC movement.
Several control experiments were done to show that the
difference in caveolin-1 polarization was not due to subtle
differences in culture conditions. The shift of caveolin-1 to
the leading extension of a transmigrating EC was not due to
the chemotactic gradient because identical polarization of
caveolin-1 was observed when basic FGF was excluded from
the lower well of the Boyden chamber (although fewer
migrating cells were observed). We also showed that the
downward movement of the transmigrating EC did not
influence caveolin-1 localization because identical results
were seen when the Boyden chamber was inverted. To de-
termine whether the difference in caveolin-1 polarization
was due to substrate differences in the two assays, a planar,
wound-induced migration assay was done using EC on a
collagen-coated polycarbonate filter (with 0.4-m pores to
prevent transmigration) as substrate. As before, caveolin-1
was preferentially localized in the rear of the EC, especially
at the perimeter of the cell body and in the retracting tail
(Figure 2V). A small amount of caveolin-1 is present in a
punctate pattern in the forward half of the moving cell, but
it is absent from the region of actin ruffling (Figure 2, W and
X). Together, these results indicate that the differential po-
larization of caveolin-1 in the two experimental models is
not due to a variant in the culture condition but rather is a
function of the dissimilar modes of cell movement.
Caveolin-1 and Caveolae Do Not Colocalize in
Transmigrating ECs
Caveolin-1 is an integral component of caveolar vesicles,
and they generally colocalize in the cell (Schnitzer et al.,
Figure 1. Caveolin-1 accumu-
lates in the forward extension of
transmigrating ECs. ECs were al-
lowed to migrate for 2 h across a
collagen-coated polycarbonate fil-
ter (8-m pore size) toward 10 ng
ml1 basic FGF in the lower com-
partment of a Boyden chamber.
The ECs were washed, fixed,
stained, and imaged by fluores-
cence confocal microscopy in a
plane through the center of the
pore. (A) EC actin visualized by
staining with Alexa Fluor 488-
phalloidin. Cells are attached to the
upper face (U) of the filter. A large
cellular protrusion into a filter pore
(white arrow) has reached the
lower face of the filter (L). (B)
Caveolin-1 was visualized by fluo-
rescence confocal microscopy by
using rabbit anti-human caveolin-1
as primary antibody followed by
biotinylated goat anti-rabbit anti-
body and Texas Red-avidin. A
three-dimensional reconstruction
of caveolin-1 immunofluorescence
in a transmigrating EC was gener-
ated from a series of xz-views. The
front is tilted downward by 20° to
facilitate visualization of the pore
in the lower face of the filter (white
arrow). (C–E) Individual xz-views
of the cell in B at 2.25-m intervals.
(F and G) Immunofluorescence im-
ages (xz-views) of caveolin-1 in other transmigrating ECs from the same experiment. (H) Immunofluorescence image of a transmigrating cell from
the same experiment, by using nonimmune, rabbit IgG instead of anti-caveolin-1 as an immunostaining control.
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Figure 2. Caveolin-1 accumu-
lates in the rear of planar-migrat-
ing ECs. (A and B) Confluent ECs
were subjected to wound-in-
duced planar migration for 24 h
in the presence of 10 ng ml1 ba-
sic FGF. The direction of overall
cell migration into the wound
area is indicated by an open ar-
row. Immunofluorescence mi-
croscopy with anti-caveolin-1 an-
tibody shows that caveolin-1 is
concentrated in the rear of most
migrating cells (arrows), but a
minority of cells (arrowheads) ex-
hibit caveolin-1 in their forward
regions. (C–E) ECs were trans-
fected with a plasmid encoding
caveolin-1-GFP and permitted to
migrate for 24 h in the presence of
10 ng ml1 basic FGF. Caveolin-
1-GFP was detected by the green
fluorescence of GFP (C), cellular
caveolin-1 was detected by im-
munostaining with anti-caveo-
lin-1 antibody and visualization
with Texas Red (D), and their co-
localization shown as yellow in a
merged image (E). (F–O) Time-
lapse video microscopy of ECs
transiently transfected with
caveolin-1-GFP and subjected to
planar, wound-induced migra-
tion. Fluorescence microscopy
images showing a single trans-
fected EC moving into the wound
area (direction indicated by open
arrow) are shown 0 (F), 6.5 (G), 10
(H), 16 (I), and 24 (J) h after the
wound was made. Transmitted
light images of the same field and
at the same times as in F–J are
shown in K–O. The leading edge
of the cell expressing caveolin-1-
GFP is indicated by the white ar-
row. (P–U) ECs were transiently
transfected with caveolin-1-GFP
(palmitoylation-mutant; see be-
low) and allowed to migrate un-
der a fluorescence microscope
camera and images recorded ev-
ery 10 min for 24 h. Images
shown were recorded after 5 h (P)
and every 200 min (Q–U). The
rear of the cell is indicated by the
open circle, and the direction and
relative velocity of the moving
cell are indicated by the arrow
and its length. (V–X) Aortic ECs
were grown to confluence on a
collagen-coated polycarbonate
filter (0.4-m pores) and induced
to migrate in the presence of 10
ng ml1 basic FGF on the surface
of the filter by wounding the
monolayer. The cells were fixed
after 24 h, caveolin-1 was visualized by immunostaining (V), actin was visualized with Alexa Fluor 488-phalloidin (W), and overlay of
caveolin-1 and actin was shown in the merged image (X).
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1995; Isshiki et al., 2002). To determine whether caveolin-1 in
transmigrating ECs is transported to the cell front with
caveolae, we used electron microscopy to visualize both
components, caveolin-1 by antibody labeling and immuno-
gold detection and caveolae by morphology. Ultrathin sec-
tions were made in the xz-plane through the center of the
pore and the body of the transmigrating cell (Figure 3A).
Confirming the results from confocal microscopy, caveolin-1
was abundant in the frontal protrusion of the EC (Figure
3C). The preponderance of the caveolin-1 in the cell front
was associated with neither the plasma membrane nor
caveolar vesicles but rather was distributed throughout the
cytoplasm. In contrast, the cell rear (and top) contained
abundant caveolae essentially devoid of caveolin-1 (Figure
3B). These caveolae were typical cave-like structures at the
plasma membrane, as well as closed structures, often in
groups, below the membrane. Electron microscopy was sim-
ilarly used to determine the location of caveolae in planar-
Figure 3. Localization of caveo-
lae in the rear of trans- and pla-
nar-migrating ECs. (A) Electron
micrograph showing the cross
section of an EC transmigrating
through the 8-m pore of a colla-
gen-coated polycarbonate filter.
Direction is indicated by open ar-
row. Caveolin-1 was detected us-
ing rabbit anti-caveolin-1 anti-
body and gold-conjugated goat
anti-rabbit IgG (5-nm particles).
Enlarged areas are indicated by
rectangles. (B) Enlarged view of
the cell rear showing abundant
caveolae (white arrows). (C) En-
larged view of the forward exten-
sion of the cell showing abundant
caveolin-1 not associated with
membrane or vesicles (black ar-
rows) or associated with caveolae
(white arrow). (D) Electron mi-
crographic image of a planar-mi-
grating EC showing a thin-slice
parallel and near to the surface of
the culture dish. Direction of
movement is indicated by open
arrow. Enlarged areas are indi-
cated by rectangles. (E) Enlarged
view of the cell front containing
no detectable caveolae. (F) En-
largement of the rear of the cell
body, with abundant caveolae
(white arrows). (D) Enlargement
of the retracting tail of the cell,
also containing caveolae (white
arrows). Scale, 3.5 m (A), 0.4 m
(B and C), and 0.5 m (E–G).
Polarization of Caveolin-1 in Cell Migration
Vol. 14, August 2003 3161
Figure 4.
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migrating ECs. Thin sections were made in the plane parallel
to and very near the dish surface (Figure 3D). The forward
lamellipodium was completely devoid of caveolae or any
other visible organelles (Figure 3E). In contrast, caveolae
were abundant at the rear of the cell body (Figure 3F) and in
the retracting tail (Figure 3G). Thus, unlike the differential
polarization of caveolin-1 and caveolae in transmigrating
ECs, caveolin-1 and caveolae are coordinately polarized dur-
ing planar migration.
Caveolin-1 Tyr14 Is Necessary for Polarization
during Transmigration but Not during Planar
Migration
We examined whether posttranslational modification of
caveolin-1 is required for its polarization during migration.
We first tested whether the transfected chimeras were sus-
ceptible to posttranslational modification. ECs were trans-
fected with plasmids driving expression of wild-type caveo-
lin-1-GFP, or with GFP-tagged caveolin-1 containing Cys-
to-Ser mutations in all three palmitoylation sites
(palmitoylation-mutant), or with a Tyr-to-Ala mutation at
the Tyr14 phosphorylation site (Tyr14-mutant). Wild-type
caveolin-1-GFP expressed by ECs was susceptible to acyla-
tion as shown by metabolic labeling of the cells with
[3H]palmitate and immunoprecipitation with anti-caveo-
lin-1 antibody; as expected, the palmitoylation mutant was
not labeled with [3H]palmitate (Figure 4A). Endogenous
caveolin-1 and -1 were equally palmitoylated in all of the
transfected cells (Figure 4B). To show that transfected caveo-
lin-1-GFP was susceptible to phosphorylation on Tyr14, ECs
were treated with H2O2 to increase the phosphorylation
level (Parat et al., 2002) and phospho-Tyr14 was detected by
immunoprecipitation of caveolin-1 and immunoblot analy-
sis with anti-phosphocaveolin-1 antibody. Tyr14-phosphor-
ylation was seen in wild-type caveolin-1-GFP but not in the
Tyr14-mutant (Figure 4C). The palmitoylation-mutant was
also susceptible to phosphorylation. This result was unex-
pected in view of a report that caveolin-1 palmitoylation was
required for its phosphorylation by c-Src (Lee et al., 2001);
however, the requirements for phosphorylation in ECs may
differ from those in Cos-7 cells cotransfected with caveolin-1
and c-Src. All transfected cells expressed similar levels of
caveolin-1-GFP (Figure 4D).
Subconfluent ECs were transfected with a plasmid encod-
ing wild-type or mutated caveolin-1-GFP, or with a control
plasmid encoding GFP alone. After recovery, the cells were
placed in the upper well of a Boyden chamber and induced
to migrate across a polycarbonate filter for 2 h. GFP in
transmigrating ECs was visualized by green fluorescence
and cellular caveolin-1 by polyclonal anti-caveolin-1 anti-
body. GFP in ECs transfected with control vector encoding
GFP alone was uniformly distributed throughout the cyto-
plasm (Figure 4E), and it did not colocalize with endogenous
caveolin-1, which was primarily located in the forward ex-
tension (Figure 4, F and G). Wild-type caveolin-1-GFP sub-
stantially colocalized with endogenous caveolin-1 in the
leading cellular extension, suggesting that the transfected
and cellular proteins undergo similar processing and traf-
ficking (Figure 4, H–J). Essentially identical results were
seen with the palmitoylation mutant, indicating that acyla-
tion is not required for caveolin-1 polarization in this model
(Figure 4, K–M). EC transfected with the Tyr14-mutant of
caveolin-1 showed markedly different results. The protein
did not show a polarized distribution, but rather was
present in discrete patches at or near the plasma membrane,
and essentially enveloping the entire cell (Figure 4, N–P).
Thus, Tyr14 of caveolin-1 is required for its polarization in
transmigrating ECs. To confirm this result, ECs were trans-
fected with a construct encoding caveolin-1-GFP; caveo-
lin-1 lacks the 31 N-terminal amino acids of caveolin-1,
and thus does not contain the Tyr14 phosphorylation site of
caveolin-1. Caveolin-1-GFP did not exhibit any front-to-
back polarization but instead was expressed in patches near
the plasma membrane and surrounding the entire cell sur-
face (Figure 4, Q–S). This distribution was essentially iden-
tical to that of the Tyr14-mutant, confirming the importance
of the Tyr14 residue for relocalization of caveolin-1 in trans-
migrating cells.
Similar methods were used to determine whether post-
translational modification of caveolin-1 was also required
for the reverse polarization in ECs during planar migration.
As described above, in ECs transfected with GFP-containing
vector control, GFP was uniformly distributed throughout
Figure 4 (facing page). Polarization of caveolin-1 in transmigrat-
ing ECs requires Tyr14 phosphorylation but not palmitoylation. (A)
ECs were transiently transfected with plasmids encoding C-termi-
nally GFP-tagged wild-type caveolin (Cav)-1 (Wt), C-terminally
GFP-tagged caveolin-1 mutated at all three palmitoylation sites
(Palm mut), or with the vector (Vect) alone. The cells were subjected
to metabolic labeling by incubation with [3H]palmitate for 4 h, and
caveolin-1 immunoprecipitated (IP) with rabbit anti-caveolin anti-
body (ab), or with nonimmune, purified rabbit IgG (IgG) as control.
The immunoprecipitate was subjected to SDS-PAGE and fluorogra-
phy. Radiolabeling of plasmid-driven, Cav-1-GFP was detected by
film exposure for 6 mo. (B) [3H]Palmitate labeling of endogenous
caveolin-1 and -1 in the same gel was detected by film exposure
for 1 mo. (C) ECs were transiently transfected with plasmids encod-
ing C-terminally GFP-tagged caveolin-1 with an Ala substitution at
Tyr14 (Tyr mut), with wild-type caveolin-1-GFP, with the palmitoyl-
ation mutant form of caveolin-1-GFP, or with the vector alone. After
recovery, the cells were incubated with medium or with H2O2 (5
mM) for 20 min. Caveolin-1 was immunoprecipitated and subjected
to SDS-PAGE. Phosphocaveolin-1-GFP was detected by immmuno-
blot analysis with anti-phosphocaveolin-1 antibody. (D) The
amount of caveolin-1-GFP expressed by all transfected cells was
shown to be nearly identical by reprobing the immmunoblot shown
in C with anti-GFP antibody. (E–G) ECs were transfected with
vector encoding GFP and permitted to transmigrate for 2 h across a
collagen-coated polycarbonate filter toward 10 ng ml1 basic FGF.
The cells were fixed and GFP was visualized by laser-scanning
confocal fluorescence analysis (E). The upper face of the filter is
indicated as U. Cellular caveolin-1 was detected with rabbit anti-
caveolin-1 as primary antibody followed by biotinylated goat anti-
rabbit antibody and Texas Red-avidin (F). Overlay of GFP fluores-
cence and cellular caveolin-1 immunostaining is shown in the
merged image (G). (H–J) ECs were transfected with vector encoding
wild-type caveolin-1-GFP, and migrating cells were treated and
analyzed as in E–G. (K–M) ECs were transfected with vector encod-
ing GFP-tagged caveolin-1 containing Cys-to-Ser mutations in all
three palmitoylation sites; migrating cells were treated and ana-
lyzed as in E–G. (N–P) ECs were transfected with vector encoding
GFP-tagged caveolin-1 containing an Ala substitution at Tyr14; mi-
grating cells were treated and analyzed as in E–G. (Q–S) ECs were
transfected with vector encoding GFP-tagged caveolin-1; migrat-
ing cells were treated and analyzed as in E–G.
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the cytoplasm and did not colocalize with cellular caveo-
lin-1, which accumulated in the rear (Figure 5, A–C). In cells
expressing wild-type caveolin-1-GFP, the exogenous protein
and endogenous caveolin-1 were colocalized in the cell rear
(Figure 5, D–F). Likewise, the chimeric palmitoylation mu-
tant and endogenous caveolin-1 also colocalized in ECs (Fig-
ure 5, G–I). Interestingly, the Tyr14-mutant colocalized with
endogenous caveolin-1, indicating that there is not a require-
ment for phosphorylation of this amino acid for polarization
during planar migration (Figure 5, J–L). Similarly, caveolin-
1-GFP also colocalized with the endogenous caveolin-1 in
planar migrating cells (Figure 5, M–O). Thus, the require-
ment for caveolin-1 Tyr14 to establish polarization is unique
to the transmigration mode of EC movement in which
caveolin-1 translocates to the cell front.
DISCUSSION
We have shown that caveolin-1 and caveolae are polarized
in migrating ECs. However, the vector of polarization of
caveolin-1 depends on the mode of migration of the cell.
Caveolin-1 accumulates in the rear of a planar-migrating cell
induced to move by wounding a monolayer, a result in
agreement with a previous report (Isshiki et al., 2002). In
contrast, caveolin-1 accumulates in the front of a transmi-
grating cell induced to traverse a filter. In both migration
modes, most caveolae accumulate in the cell rear, and caveo-
lin-1 in the front of a transmigrating cell is primarily not
associated with caveolae. Our results indicate that modes of
cell migration that clearly differ in their morphological char-
acteristics also differ in well-defined biochemical properties.
A similar conclusion was made to explain the presence of
lipid rafts in the leading edge of insulin growth factor-1–
stimulated MCF-7 cells but in the rear of moving T lympho-
cytes (Man˜es et al., 1999; Go´mez-Mouto´n et al., 2001). These
authors hypothesized that the difference in polarization is
due to the different migration strategies of the two cells: in
“crawling” MCF-7 cells, like fibroblasts, the pseudopodia in
the leading edge attach tightly to their substrate via integrins
and adhesion receptors, whereas the leading edges of “glid-
ing” T cells attach less strongly to the substrate and exhibit
fewer integrins and adhesion receptors. Our results differ in
that caveolae was found in the rear of both planar- and
trans-migrating ECs. However, our finding of differential
polarization of caveolin-1 under different conditions in the
same cell type, establishes that polarization of the protein,
and possibly other motility-related proteins, depends on the
mode of migration.
Our results show that transmigrating ECs contain a pool
of cytoplasmic caveolin-1 in the forward extension, and a
pool of caveolae at the rear of the cell that are essentially
devoid of caveolin-1. This result is unexpected given the
generally held concept that caveolin-1 is a membrane-bound
protein incorporated into caveolae. However, evidence is
accumulating for the existence of both soluble caveolin-1
and caveolin-1–deficient caveolae. Soluble caveolin-1 has
been observed in the lumen of the endoplasmic reticulum, in
secretory vesicles, and in the matrix of mitochondria (Smart
et al., 1994; Liu et al., 1999; Li et al., 2001). A soluble, cyto-
plasmic form has been detected by biochemical (Uittenbo-
gaard et al., 1998) and imaging (Li et al., 2001) methods. A
recent model of the intracellular itinerary of caveolin-1 pro-
poses that soluble caveolin-1 is released after its incorpora-
tion into caveolae (Liu et al., 2002b). The existence of caveo-
lae without caveolin is more controversial, because
caveolin-1 seems to be the structural molecule of the fila-
mentous coat decorating the cytosolic surface of caveolae
(Fernandez et al., 2002). In addition, some cells that lack
caveolin-1 also lack caveolae, and expression of exogenous
caveolin-1 in these cells induces caveolae formation (Fra et
al., 1995). However, a recent study suggests that caveolin-1 is
not necessary for caveolae invaginations, but rather is a
negative regulator of caveolae endocytosis (Le et al., 2002).
These authors show that in cells lacking caveolin-1, caveolae
endocytosis is so rapid that caveolae cannot be detected by
electron microscopy, whereas in cells expressing caveolin-1,
the slower rate of endocytosis permits caveolae visualization
in thin-section images. They also show that overexpression
of a dominant-negative form of dynamin (K44A) slows
caveolae internalization and induces caveolar invagination
in caveolin- and caveolae-deficient, abl-transformed NIH-
3T3 cells. These caveolae occur without any concomitant
increase in caveolin-1 expression, and they are essentially
devoid of immunogold-detectable caveolin-1, in agreement
with our finding of caveolin-1–free caveolae at the rear of
transmigrating ECs. In view of these results, we propose a
model of cell movement in which both caveolae and caveo-
lin-1 accumulate in the rear of planar-migrating cells, and
that upon initiation of transmigration, caveolin-1 is released
from caveolae and translocates in a soluble form to the cell
front (Figure 6).
Transfection of ECs with GFP-tagged caveolin-1 con-
structs show that caveolin-1 does not translocate to the
forward extension of a trans-migrating cell, but rather is
retained in plasma membrane patches surrounding the en-
tire cell. Not much is known about the expression or func-
tion of caveolin-1, and in particular, differences between -
and -isoforms. Insect cell expression of caveolin-1 (or -1)
causes formation of vesicles resembling caveolae by their
size, buoyant density, and caveolin-1 enrichment (Li et al.,
1996). Similarly, overexpression of caveolin-1 in Chinese
hamster ovary cells induces caveolae formation, although
less efficiently than the -isoform (Fujimoto et al., 2000).
Figure 5 (facing page). Polarization of caveolin-1 in planar-mi-
grating ECs requires neither Tyr14 phosphorylation nor palmitoyl-
ation. (A–C) ECs were transfected with vector encoding GFP and
subjected to planar, wound-induced migration for 24 h in the pres-
ence of 10 ng ml1 basic FGF. The cells were fixed, and GFP was
visualized by confocal fluorescence microscopy (A). Cellular caveo-
lin-1 was detected with rabbit anti-caveolin-1 as primary antibody
followed by biotinylated goat anti-rabbit antibody and Texas Red-
avidin (B). Overlay of GFP fluorescence and cellular caveolin-1
immunostaining is shown in the merged image (C). (D–F) ECs were
transfected with vector encoding wild-type caveolin-1-GFP, and
migrating cells were treated and analyzed as in A–C. (G–I) ECs were
transfected with vector expressing GFP-tagged caveolin-1 contain-
ing Cys-to-Ser mutations in all three palmitoylation sites; migrating
cells were treated and analyzed as in A–C. (J–L) ECs were trans-
fected with vector expressing GFP-tagged caveolin-1 containing an
Ala substitution at Tyr14; migrating cells were treated and analyzed
as in A–C. (M–O) ECs were transfected with vector expressing
GFP-tagged caveolin-1-; migrating cells were treated and analyzed
as in A–C.
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These results suggest the possibility that caveolae in the rear
of a transmigrating EC are maintained by the pool of caveo-
lin-1, which does not translocate to the cell front. Our
finding that essentially no immunogold-detectable caveo-
lin-1 remains in the rear of a transmigrating cell seems to
contradict this function of caveolin-1. However, given the
relatively weak caveolin-1 signal given by this antibody in
denaturing conditions with EC (Parat and Fox, 2001) or
fibroblast (Fujimoto et al., 2000) lysates, and the broad dis-
tribution of the -isoform around the entire cell surface, it is
possible that the caveolae near the back of transmigrating
ECs indeed contain caveolin-1-, but that it is undetectable
in our experiments.
The cellular function of caveolin-1 and caveolae during
migration remains unclear, but at least three mechanisms
should be considered, namely, effects on the cytoskeleton,
signaling, and cholesterol transport. An influence of caveo-
lin-1 on cytoskeletal function is suggested by the binding of
caveolin-1 to the actin cross-linking protein filamin and their
alignment with Rho-induced stress fibers (Stahlhut and van
Deurs, 2000). Caveolin-1 overexpression blocked epidermal
growth factor-activated formation of F-actin stress fibers in
lamellipodia (Zhang et al., 2000). The apparent localization
of phosphocaveolin-1 at focal adhesion sites also suggests an
association with the cytoskeleton (Lee et al., 2000; Volonte et
al., 2001). Indeed, cytoskeletal disruption potentiates the
phosphorylation of caveolin-1 on Tyr14 induced by hyper-
osmotic shock (Volonte et al., 2001), and caveolin-1 depletion
causes loss of focal adhesion sites and cell adhesion (Wei et
al., 1999). Caveolin-1 may differentially regulate motility-
related cytoskeletal components during two- and three-di-
mensional movement. The well-known role of caveolae and
caveolin-1 in compartmentalization and regulation of signal-
ing complexes (Shaul and Anderson, 1998; Smart et al., 1999)
suggests that caveolin-1 might influence signal transduction
processes involved in cell migration. In support of this hy-
pothesis, polarization of caveolae (in shear-stressed ECs) has
been shown to correlate with calcium wave initiation (Isshiki
et al., 2002). Moreover, caveolin-1 cofractionates with the
Rho family GTPases RhoA Rac1 and Cdc42, although a
direct interaction has only been shown for RhoA (Gingras et
al., 1998; Michaely et al., 1999). Caveolin-1 copolarizes with
the urokinase receptor at the leading edge of migrating
smooth muscle cells (Okada et al., 1995), and both may
interact with -1 integrins in a complex that regulates adhe-
sion and signaling through Src-family kinases and focal
adhesion kinase (Chapman et al., 1999). It is interesting to
speculate that there may be migration mode-specific signal-
ing molecules that are spatially regulated by caveolin. Fi-
nally, caveolin-1 and caveolae may regulate cell motility via
their ability to transport newly synthesized cholesterol from
endoplasmic reticulum to plasma membranes (Smart et al.,
1996; Uittenbogaard et al., 1998). Membrane cholesterol may
be an important determinant of EC migration because inhib-
itors of cholesterol synthesis inhibit cell migration (Axel et
al., 2000; Vincent et al., 2001), and addition of small amounts
of cholesterol to ECs increases migration (Ghosh et al., 2002).
Alternatively, caveolae may provide membrane lipids to the
expanding forward extension of a moving cell in a manner
similar to the proposed polarized delivery of endocytosed
clathrin-coated vesicles to the membrane of moving cells
(Bretscher and Aguado-Velasco, 1998). The extremely rapid
intracellular movement of caveolin-1 and caveolin-1-associ-
ated vesicles is consistent with an important role in cell
transport processes (Mundy et al., 2002).
Our transfection experiments with caveolin-1 mutants in-
dicate that phosphorylation of caveolin-1 on Tyr14 (or pos-
sibly the Tyr14 residue itself) is required for caveolin-1 ac-
cumulation in the leading extension of transmigrating ECs.
The mechanism by which caveolin-1 accumulates in this
region is not known. A previous report suggests that phos-
phorylation of Tyr14 is required for caveolin-1 binding to
Grb7, a Src homology 2-containing adapter protein that
regulates cell motility, and for enhanced chemotaxis of 293T
cells cotransfected with caveolin-1, c-Src and Grb7 (Lee et al.,
2000). It is possible that the interaction with Grb7 may be
part of the mechanism driving caveolin-1 to the front of
transmigrating cells. In contrast to the requirement for phos-
phorylation, mutation of all three palmitoylation sites of
caveolin-1 did not affect its polarization in transmigrating
cells. This was unexpected in view of the requirement of
caveolin-1 palmitoylation on Cys156 for its interaction with
c-Src, and consequently, for c-Src-mediated phosphorylation
on Tyr14 (Lee et al., 2000; Lee et al., 2001). Possibly, other
kinases phosphorylate caveolin-1 in migrating ECs. This
hypothesis is supported by our data showing that palmi-
toylation is not required for H2O2-induced phosphorylation,
and by a recent report indicating that c-Abl rather than c-Src
is responsible for the H2O2-induced caveolin-1 phosphory-
lation (Sanguinetti and Mastick, 2003).
The polarization of caveolin-1 during EC movement sug-
gests that it may have an important role in this process. This
Figure 6. Model showing polarization of caveolin-1 and caveolae in planar- and trans-migrating ECs. Caveolae are indicated by open circles,
and caveolin-1 is indicated by dotted regions.
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idea is in agreement with recent studies showing that EC
caveolin-1 contributes to capillary formation in vivo and in
vitro. In several rat tissues examined, phospho-Tyr14-caveo-
lin-1 is most abundant in the endothelium of capillaries and
small venules (Aoki et al., 1999). Activators of angiogenesis
cause decreased expression of caveolae and caveolin-1 in
cultured ECV 304 cells. Antisense-mediated down-regula-
tion of caveolin-1 in ECs reduced capillary tubule formation
in vitro and in vivo (Griffoni et al., 2000; Liu et al., 2002a).
Likewise, overexpression of caveolin-1 in microvascular ECs
increased capillary tubule formation in vitro (Liu et al.,
2002a) and intracellular delivery of caveolin-1 scaffolding
domain enhanced tube formation (Griffoni et al., 2000). In
contrast, exogenous expression of caveolin-1 in caveolin-1-
deficient MTLn3 metastatic cells reduced epidermal growth
factor-stimulated lamellipodial extension and chemotaxis
(Zhang et al., 2000). Future studies of the mechanisms driv-
ing caveolae and caveolin-1 polarization may permit the
development of reagents that can differentially modulate the
migration of ECs in vivo, for example, by inhibiting the EC
trans-migration that drives angiogenesis without altering
the wound-healing properties of the endothelium.
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